Akèy › Karsinòm selil skuamèz tèt ak kou › Arkansas
Etid klinik pou Karsinòm selil skuamèz tèt ak kou nan Arkansas
11 etid pou Karsinòm selil skuamèz tèt ak kou ap chèche patisipan nan sit nan Arkansas.
Vil nan Arkansas
Tèks ofisyèl etid la (Anglè)
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
- University of Arkansas for Medical Sciences, Little Rock
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06992427Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- University of Arkansas for Medical Sciences, Little Rock
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06589804BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- University of Arkansas for Medical Sciences, Little Rock
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT05136196Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- University of Arkansas for Medical Sciences, Little Rock
Ap rekriteFaz 2
Laj 18 a 79 · Tout sèks · Mizajou Sep 22, 2026 · NCT04671667Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
- Highlands Oncology Group, PA, Fayetteville
- University of Arkansas for Medical Sciences, Little Rock
- Highlands Oncology Group, PA, Rogers
- ak 1 plis
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Sep 15, 2026 · NCT05952934Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT02734537ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
- Highlands Oncology Group, Rogers
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06597721Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
- University of Arkansas for Medical Sciences, Little Rock
Ap rekriteFaz 2/3
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT04333537Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT06532279A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Highlands Oncology Group, Fayetteville
- Highlands Oncology Group, Rogers
- Highlands Oncology Group, Springdale
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT04389632A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- GSK Investigational Site, Jonesboro
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou May 26, 2026 · NCT06256588Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.